Search

In an on-going effort to discover metallotherapeutic alternatives to the chemotherapy drug cisplatin, neutral distorted square pyramidal gold(III) coordination complexes possessing 2,9-disubstituted-1,10-phenanthroline ligands {[((R)phen)AuCl3]; R = n-butyl, sec-butyl} have been previously synthesized and characterized. A structurally analogous gold(III) complex bearing a 6,6'-di-methylbipyridine ligand ([((methyl)bipy)AuCl3]) has been synthesized and fully characterized to probe the effect of differing aromatic character of the ligand on solution stability and tumor cell cytotoxicity. The two compounds [((sec-butyl)phen)AuCl3] and [((methyl)bipy)AuCl3]) were subsequently assessed for their stability against the biological reductant glutathione, and it was found that the [((sec-butyl)phen)AuCl3] complex exhibits slightly enhanced stability compared to the [((methyl)bipy)AuCl3] complex and significantly higher stability than previously reported square planar gold(III) complex ions. Furthermore, these complexes were tested for cytotoxic effects against existing lung and head and neck cancer cell lines in vitro. The [((sec-butyl)phen)AuCl3] complex was found to be more cytotoxic than cisplatin against five different tumor cell lines, whereas [((methyl)bipy)AuCl3] had more limited in vitro antitumor activity. Given that [((sec-butyl)phen)AuCl3] had significantly higher antitumor activity, it was tested against an in vivo tumor model. It was found that this complex did not significantly reduce the growth of xenograft tumors in mice and initial model binding studies with bovine serum albumin indicate that interactions with serum albumin proteins may be the cause for the limited in vivo activity of this potential metallotherapeutic., (© 2013.)

Luminescent ligands in Ir(III) cyclometalated complexes. The photophysical and photochemical properties of Ir-cyclometalated complexes containing luminescent ligands are evaluated (see figure). Significant admixture between Ir and ligand orbitals induces an efficient intersystem crossing. Photochemical reactions performed in the presence of oxygen lead to new Ir-cyclometalated complexes containing N(amido) groups directly bound to Ir.A series of phosphorescent cyclometalated heteroleptic iridi um(III) phenylpyridinato (ppy) complexes containing luminescent 1-pyridylimidazo[1,5-alpha]pyridine (pip) ligands, namely [Ir(ppy)(2)(pip)](+), have been synthesised, characterised and their electrochemical, photophysical and electronic properties studied. Seven X-ray structures have been resolved. Excitation of [Ir(ppy)(2)(pip)](+) in acetonitrile at room temperature results in a dual luminescence, strongly quenched by O(2). Four complexes show, in absence of O(2), a high-energy emission (assigned to a (3)MLLCT transition) with two maxima in the blue region of the visible spectra, and a second structured emission (assigned largely to a (3)LC pi-pi* transition) centred around lambda=555 nm. Lifetimes of high-energy emissions are between 0.6 and 1.3 mus. Time-dependent density functional calculations combined with the conductor-like polarisable continuum model method, with acetonitrile as solvent, have been used to calculate a series of ground and excited states of the derivatives under investigation, and the transitions compared with the experimental UV/Vis absorption spectra. A quick and efficient photochemical reaction has been observed for these iridium derivatives that leads to the formation of a new class of cyclometalated iridium complexes containing a stable deprotonated amide unusually coordinated to the metal through a nitrogen bond. The synthesis of a (15)N enriched selected ligand has been performed to investigate, by means of NMR, the particular facile route to these new set of derivatives. The electrochemical behaviour of all complexes is also reported.

The complex [Ru(tpy)(CO)(2)TFA]+[PF(6)]- (where tpy = 2,2':6',2' '-terpyridine and TFA = CF(3)CO(2)-) (1) has been synthesized and fully characterized spectroscopically. The X-ray structure of the complex has been determined. The photopysical properties of the ruthenium complex and the free ligand tpy have been investigated at room temperature and at 77 K in acetonitrile solution and in the solid state. Their electronic spectra are highly influenced by intermolecular stacking interactions, both in solution and in the solid state. Density functional theory (DFT) and time-dependent DFT (TDDFT) calculations have been performed to characterize the electronic structure and the excited states of [Ru(tpy)(CO)(2)TFA]+[PF(6)]- and tpy. TDDFT calculations on three different conformations of free ligand have been performed as well. Absorption and emission spectra of tpy have been studied at different temperatures and concentrations in order to have a better understanding of this ruthenium derivative's properties. The absorption spectrum of 1 is characterized by metal-perturbed ligand-centered (LC) bands in the UV region. No metal-to-ligand charge transfer (MLCT) bands are observed in the visible for the complex. Only at high concentrations (10(-4) M) does a very weak band appear at 470 nm. At 77 K and low concentrations, solutions of 1 exhibit a major 3LC emission band centered at 468 nm (21.4 x 10(-3) cm(-1)). When the concentration of the complex is increased, an unstructured narrow emission at 603 nm (16.6 x 10(-3) cm(-1)), with a lifetime of 10 micros, dominates the emission spectrum in glassy acetonitrile. This emission originates from a pi-pi stacked dimeric (or oligomeric) species. TDDFT calculations performed on a tail-to-tail dimer structure, similar to that seen in the solid state, ascribe the transition to a triplet excited state, where intermolecular metal (d) --> ligand (pi*, polypyridine) charge transfer occurs. A good estimate of the transition energy is also obtained (623 nm, 1.94 eV).